Preclinical studies of LentiVIP transduced mesenchymal stromal cells for the treatment of multiple sclerosis
Por:
Cobo, M, Abril, D, Delgado, M, Gonzalez-Rey, E, Menendez, P, Anderson, P, Rodriguez, R and Martin, F
Publicada:
1 dic 2017
Resumen:
Filiaciones:
Cobo, M:
Pfizer Univ Granada Junta Andalucia, GENyO Ctr Genom & Invest Oncol, Granada, Spain
LentiStem Biotech, Granada, Spain
Abril, D:
Pfizer Univ Granada Junta Andalucia, GENyO Ctr Genom & Invest Oncol, Granada, Spain
Delgado, M:
IPB Lopez Neyra, Granada, Spain
Gonzalez-Rey, E:
IPB Lopez Neyra, Granada, Spain
:
Josep Carreras Leukaemia Res Inst, Barcelona, Spain
Anderson, P:
Pfizer Univ Granada Junta Andalucia, GENyO Ctr Genom & Invest Oncol, Granada, Spain
Rodriguez, R:
Inst Invest Sanitaria Principado Asturias, Oviedo, Spain
Martin, F:
Pfizer Univ Granada Junta Andalucia, GENyO Ctr Genom & Invest Oncol, Granada, Spain
Cardioctr Ticino, Lugano, Switzerland.
|